| Dr Shelley Dawn Kasprick, DC | |
|
4747 Kilauea Ave #107, Honolulu, HI 96816 | |
| (808) 732-2244 | |
| (808) 732-4244 |
| Full Name | Dr Shelley Dawn Kasprick |
|---|---|
| Gender | Female |
| Speciality | Chiropractic |
| Experience | 20 Years |
| Location | 4747 Kilauea Ave #107, Honolulu, Hawaii |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689770430 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111N00000X | Chiropractor | 1309 (Hawaii) | Secondary |
| 111NS0005X | Chiropractor - Sports Physician | 6348142-1202 (Utah) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Red Valley Chiropractic And Massage Inc | 8527160084 | 2 |
News Archive
Cloning, X-chromosome inactivation, stem cells, and embryogenesis are hot areas of research at the moment, and protocols featured in this month's release of Cold Spring Harbor Protocols will aid these studies.
Kaiser Health News: "The health care overhaul debate in Congress now centers on two bills: the House-passed measure and the Senate Democrats' version unveiled Wednesday. They differ in important ways." KHN provides a consumers' guide that discusses mandates, new regulations on health insurers and how the legislation would affect both the insured and uninsured (Appleby, Carey, Galewitz and Rau, 11/19).
In stroke patients in whom intravenous thrombolysis is either contraindicated or has failed, intra-arterial revascularization with cerebral angioplasty and stent placement is an effective and well-tolerated treatment, say Czech researchers.
The Spanish Head and Neck Cancer Cooperative Group (TTCC) announced today that Induction Chemotherapy (IC) delivered prior to standard ChemoRadiotherapy (CRT), a treatment paradigm defined as sequential therapy, compared to upfront CRT alone, significantly prolonged Time-to-Treatment Failure (TTF) for patients with unresectable Locally Advanced Head and Neck Cancer (LAHNC).
Harbor Biosciences, a biopharmaceutical company developing novel therapeutics for the treatment of cancer, metabolic and inflammatory diseases, today released an update to its development program for Triolex to treat obesity-induced insulin resistance and type-2 diabetes mellitus (T2DM).
› Verified 7 days ago
| Provider Name | Red Valley Chiropractic And Massage Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1821472168 PECOS PAC ID: 8527160084 Enrollment ID: O20210618001736 |
News Archive
Cloning, X-chromosome inactivation, stem cells, and embryogenesis are hot areas of research at the moment, and protocols featured in this month's release of Cold Spring Harbor Protocols will aid these studies.
Kaiser Health News: "The health care overhaul debate in Congress now centers on two bills: the House-passed measure and the Senate Democrats' version unveiled Wednesday. They differ in important ways." KHN provides a consumers' guide that discusses mandates, new regulations on health insurers and how the legislation would affect both the insured and uninsured (Appleby, Carey, Galewitz and Rau, 11/19).
In stroke patients in whom intravenous thrombolysis is either contraindicated or has failed, intra-arterial revascularization with cerebral angioplasty and stent placement is an effective and well-tolerated treatment, say Czech researchers.
The Spanish Head and Neck Cancer Cooperative Group (TTCC) announced today that Induction Chemotherapy (IC) delivered prior to standard ChemoRadiotherapy (CRT), a treatment paradigm defined as sequential therapy, compared to upfront CRT alone, significantly prolonged Time-to-Treatment Failure (TTF) for patients with unresectable Locally Advanced Head and Neck Cancer (LAHNC).
Harbor Biosciences, a biopharmaceutical company developing novel therapeutics for the treatment of cancer, metabolic and inflammatory diseases, today released an update to its development program for Triolex to treat obesity-induced insulin resistance and type-2 diabetes mellitus (T2DM).
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Shelley Dawn Kasprick, DC 267 N Main St, Ste B, Moab, UT 84532-2342 Ph: (435) 259-0123 | Dr Shelley Dawn Kasprick, DC 4747 Kilauea Ave #107, Honolulu, HI 96816 Ph: (808) 732-2244 |
News Archive
Cloning, X-chromosome inactivation, stem cells, and embryogenesis are hot areas of research at the moment, and protocols featured in this month's release of Cold Spring Harbor Protocols will aid these studies.
Kaiser Health News: "The health care overhaul debate in Congress now centers on two bills: the House-passed measure and the Senate Democrats' version unveiled Wednesday. They differ in important ways." KHN provides a consumers' guide that discusses mandates, new regulations on health insurers and how the legislation would affect both the insured and uninsured (Appleby, Carey, Galewitz and Rau, 11/19).
In stroke patients in whom intravenous thrombolysis is either contraindicated or has failed, intra-arterial revascularization with cerebral angioplasty and stent placement is an effective and well-tolerated treatment, say Czech researchers.
The Spanish Head and Neck Cancer Cooperative Group (TTCC) announced today that Induction Chemotherapy (IC) delivered prior to standard ChemoRadiotherapy (CRT), a treatment paradigm defined as sequential therapy, compared to upfront CRT alone, significantly prolonged Time-to-Treatment Failure (TTF) for patients with unresectable Locally Advanced Head and Neck Cancer (LAHNC).
Harbor Biosciences, a biopharmaceutical company developing novel therapeutics for the treatment of cancer, metabolic and inflammatory diseases, today released an update to its development program for Triolex to treat obesity-induced insulin resistance and type-2 diabetes mellitus (T2DM).
› Verified 7 days ago
Beverly Bigbee, DC Chiropractor Medicare: Medicare Enrolled Practice Location: 1221 Kapiolani Blvd, Suite 6a3, Honolulu, HI 96814 Phone: 808-591-8426 | |
Dr. Scott Tobi Hirashiki, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1481 S. King St., #321, Honolulu, HI 96814 Phone: 808-946-4459 Fax: 808-946-8377 | |
Dr. Glenn Thomas Poulain, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 3049 Ualena St, Suite 104, Honolulu, HI 96819 Phone: 808-834-8662 | |
Dr. Francis G Brewer, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1150 S King St, Suite 604, Honolulu, HI 96814 Phone: 808-593-0313 Fax: 808-589-2032 | |
Piianaia Ohana Chiropractic Inc Chiropractor Medicare: Medicare Enrolled Practice Location: 3221 Waialae Avenue, Ste 330, Honolulu, HI 96816 Phone: 808-735-8749 Fax: 808-734-2766 | |
Dr. Joseph Patrick Breuwet, D.C. Chiropractor Medicare: May Accept Medicare Assignments Practice Location: 1600 Kapiolani Blvd, Suite 1421, Honolulu, HI 96814 Phone: 808-638-1313 Fax: 808-942-9493 | |
Howard Tang D.c.p.c. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1191 Bethel Street, Honolulu, HI 96813 Phone: 808-524-9913 Fax: 808-524-8815 |